Ac Immune SA

Form 420-F

Insider Trading (Form 4)

See all →
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune Director Receives Equity Awards
AC Immune SA reports that Director Roy Ervin Twyman was granted restricted stock units and stock options on June 11, 2026.
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune Director Receives Equity Awards
AC Immune SA director Renee Aguiar-Lucander was granted restricted stock units and stock options on June 11, 2026.
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune SA: Director Receives Equity Awards
AC Immune SA reports that Director Martin Zuegel was granted restricted stock units and stock options on June 11, 2026.
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune Director Acquires Shares and Options
AC Immune SA reports that Director Monika Buetler acquired 17,751 restricted share units and 41,667 share options.
NASDAQ
ACIU
Ac Immune SA
Form 4: Director Carl Howard Receives Equity Awards
AC Immune SA Director Carl Howard was granted restricted stock units and stock options on June 11, 2026, as disclosed in a Form 4 filing.
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune CEO Sells Shares Under 10b5-1 Plan
AC Immune SA's CEO, Andrea Pfeifer, reported the sale of 10,000 common shares for $2.7935 each under a pre-arranged trading plan.